{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:13:38Z","timestamp":1792242818525,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mcn.2026.104091","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:34:37Z","timestamp":1776724477000},"page":"104091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review"],"prefix":"10.1016","volume":"137","author":[{"given":"Eve","family":"Corcoran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kettlety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urwa","family":"Mogul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Ndiforngwah","family":"Azah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Cork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2009.06.035","article-title":"Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer\u2019s disease","volume":"205","author":"Abbas","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"24","key":"10.1016\/j.mcn.2026.104091_bb0010","article-title":"Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia","volume":"8","author":"Abdel-Rady","year":"2020","journal-title":"Phys. Rep."},{"issue":"12","key":"10.1016\/j.mcn.2026.104091_bb0015","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mcn.2026.104091_bb0020","doi-asserted-by":"crossref","first-page":"111932","DOI":"10.1016\/j.bbr.2019.111932","article-title":"Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5\u00d7FAD mouse model of Alzheimer\u2019s disease","volume":"370","author":"An","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mcn.2026.104091_bb0025","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2026.104091_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/578373","article-title":"Tau phosphorylation by GSK3 in different conditions","volume":"2012","author":"Avila","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4239\/wjd.v5.i6.889","article-title":"Type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"5","author":"Barbagallo","year":"2014","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non- human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0045","doi-asserted-by":"crossref","first-page":"bqae165","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"B\u00f6rchers","year":"2025","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10\u00a0years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.mcn.2026.104091_bb0055","doi-asserted-by":"crossref","first-page":"741923","DOI":"10.3389\/fnagi.2021.741923","article-title":"Liraglutide reduces vascular damage, neuronal loss, and cognitive impairment in a mixed murine model of Alzheimer\u2019s disease and type 2 diabetes","volume":"13","author":"Carranza-Naval","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.mcn.2026.104091_bb0060","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide improves water maze learning and memory performance while reduces hyperphosphorylation of tau and neurofilaments in APP\/PS1\/tau triple transgenic mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-024-01497-4","article-title":"Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Chen","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/mds.28551","article-title":"Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression","volume":"36","author":"Chohan","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2026.104091_bb0075","article-title":"Exploring the link between GLP-1 receptor agonists and dementia: a comprehensive review","volume":"9","author":"Chuansangeam","year":"2025","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"issue":"10","key":"10.1016\/j.mcn.2026.104091_bb0080","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.mcn.2026.104091_bb0085","article-title":"Efficacy and safety of oral semaglutide 14\u00a0mg (flexible dose) in early-stage symptomatic Alzheimer\u2019s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials","volume":"0","author":"Cummings","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2026.104091_bb0090","doi-asserted-by":"crossref","first-page":"102726","DOI":"10.1016\/j.eclinm.2024.102726","article-title":"12-Month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study","volume":"74","author":"De Giorgi","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1476-5381.2011.01687.x","article-title":"The structure and function of the glucagon-like peptide-1 receptor and its ligands","volume":"166","author":"Donnelly","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.mcn.2026.104091_bb0100","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/ijms21051746","article-title":"Liraglutide protects against brain amyloid-\u03b21\u201342 accumulation in female mice with early Alzheimer\u2019s disease-like pathology by partially rescuing oxidative\/nitrosative stress and inflammation","volume":"21","author":"Duarte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2026.104091_bb0105","doi-asserted-by":"crossref","first-page":"177305","DOI":"10.1016\/j.ejphar.2025.177305","article-title":"The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy\/ACE2\/SIRT1\/FOXO1-mediated microglia polarization","volume":"991","author":"Elbadawy","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0110","doi-asserted-by":"crossref","first-page":"e133429","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.mcn.2026.104091_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2019.04.006","article-title":"Exendin-4 attenuates brain mitochondrial toxicity through PI3K\/Akt-dependent pathway in amyloid beta (1\u201342)-induced cognitive deficit rats","volume":"128","author":"Garabadu","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mcn.2026.104091_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2026.104091_bb0125","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.molmet.2024.102019","article-title":"The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice","volume":"89","author":"Germano","year":"2024","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0130","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J. Diabetes Investig."},{"issue":"3","key":"10.1016\/j.mcn.2026.104091_bb0390","doi-asserted-by":"crossref","first-page":"341","DOI":"10.32598\/bcn.2021.2554.2","article-title":"Investigating the Glucagon-like Peptide-1 and Its Receptor in Human Brain: Distribution of Expression, Functional Implications, Age-related Changes and Species Specific Characteristics","volume":"14","author":"Gupta","year":"2023","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.mcn.2026.104091_bb0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2015.12.052","article-title":"The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy","volume":"1634","author":"Hansen","year":"2016","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.mcn.2026.104091_bb0145","doi-asserted-by":"crossref","first-page":"e0158205","DOI":"10.1371\/journal.pone.0158205","article-title":"Long-term treatment with Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on \u03b2-amyloid plaque load in two transgenic APP\/PS1 mouse models of Alzheimer\u2019s disease","volume":"11","author":"Hansen","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mcn.2026.104091_bb0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200705042","article-title":"Deletion of tumor necrosis factor death receptor inhibits amyloid \u03b2 generation and prevents learning and memory deficits in Alzheimer\u2019s mice","volume":"178","author":"He","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mcn.2026.104091_bb0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuropharm.2018.11.002","article-title":"Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of \u03b2-amyloid pathology","volume":"144","author":"Holubov\u00e1","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2026.104091_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"issue":"5","key":"10.1016\/j.mcn.2026.104091_bb0165","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/ijms21051725","article-title":"Liraglutide suppresses tau hyperphosphorylation, amyloid beta accumulation through regulating neuronal insulin signaling and BACE-1 activity","volume":"21","author":"Jantrapirom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-023-00718-2","article-title":"Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt\/\u03b2-catenin\/NeuroD1 pathway","volume":"29","author":"Kang","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.mcn.2026.104091_bb0385","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.mcn.2026.104091_bb0175","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2147\/NDT.S260160","article-title":"Liraglutide attenuates A\u03b242 generation in APPswe\/SH-SY5Y cells through the regulation of autophagy","volume":"16","author":"Kong","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13195-024-01573-x","article-title":"Inflammatory proteins associated with Alzheimer\u2019s disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial","volume":"16","author":"Koychev","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"47","key":"10.1016\/j.mcn.2026.104091_bb0185","doi-asserted-by":"crossref","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mcn.2026.104091_bb0190","doi-asserted-by":"crossref","first-page":"e2521016","DOI":"10.1001\/jamanetworkopen.2025.21016","article-title":"Neurodegeneration and stroke after semaglutide and tirzepatide in patients with diabetes and obesity","volume":"8","author":"Lin","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"24","key":"10.1016\/j.mcn.2026.104091_bb0195","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2026.104091_bb0200","doi-asserted-by":"crossref","first-page":"1531289","DOI":"10.1155\/2022\/1531289","article-title":"The impact of diabetes on vascular disease: progress from the perspective of epidemics and treatments","volume":"2022","author":"Liu","year":"2022","journal-title":"J. Diabetes Res."},{"issue":"4","key":"10.1016\/j.mcn.2026.104091_bb0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/01616412.2016.1145914","article-title":"Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway","volume":"38","author":"Liu","year":"2016","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.mcn.2026.104091_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1507\/endocrj.EJ23-0723","article-title":"Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating \u03b2-secretase and \u03b3-secretase and alleviating oxidative stress in HT-22 cells","volume":"72","author":"Ma","year":"2025","journal-title":"Endocr. J."},{"key":"10.1016\/j.mcn.2026.104091_bb0215","doi-asserted-by":"crossref","first-page":"107866","DOI":"10.1016\/j.phrs.2025.107866","article-title":"Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study","volume":"219","author":"Marassi","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.mcn.2026.104091_bb0220","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1007\/s00210-025-03932-3","article-title":"Efficacy and safety of GLP-1 agonists in Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"398","author":"Messak","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.mcn.2026.104091_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1567205016666190913155950","article-title":"A pilot study of exenatide actions in Alzheimer\u2019s disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0230","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"N\u00f8rgaard","year":"2022","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Intervent."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0235","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/ijms22020860","article-title":"Liraglutide has anti-inflammatory and anti-amyloid properties in Streptozotocin-induced and 5xFAD mouse models of Alzheimer\u2019s disease","volume":"22","author":"Paladugu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mcn.2026.104091_bb0240","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.apsb.2022.06.003","article-title":"The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs\u2014therapeutic potential exploration in lung injury","volume":"12","author":"Pang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.mcn.2026.104091_bb0250","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2174\/1567205018666210929150004","article-title":"Exendin-4 improves cognitive function of diabetic mice via increasing brain insulin synthesis","volume":"18","author":"Peng","year":"2021","journal-title":"Curr. Alzheimer Res."},{"issue":"13","key":"10.1016\/j.mcn.2026.104091_bb0255","doi-asserted-by":"crossref","first-page":"10449","DOI":"10.3390\/ijms241310449","article-title":"Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2026.104091_bb0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3\u03b2 pathway in an amyloid \u03b2 protein induced Alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0265","first-page":"247","article-title":"Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3\u03b2","volume":"9","author":"Qi","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.mcn.2026.104091_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13293-016-0059-9","article-title":"Sex and estrogens alter the action of glucagon-like peptide-1 on reward","volume":"7","author":"Richard","year":"2016","journal-title":"Biol. Sex Differ."},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-328X(97)00356-2","article-title":"Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor\/interleukin-6 complex","volume":"55","author":"Ringheim","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.mcn.2026.104091_bb0280","doi-asserted-by":"crossref","first-page":"115474","DOI":"10.1016\/j.bcp.2023.115474","article-title":"Erratum in: Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer\u2019s and Parkinson\u2019s disease therapeutics. Biochem Pharmacol. 2020 Oct;180:114187. doi:10.1016\/j.bcp.2020.114187. Epub 2020 Aug 2","volume":"210","author":"Salameh","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.mcn.2026.104091_bb0285","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2026.104091_bb0290","doi-asserted-by":"crossref","first-page":"151016","DOI":"10.1016\/j.bbrc.2024.151016","article-title":"GLP-1 receptor signaling restores aquaporin 4 subcellular polarization in reactive astrocytes and promotes amyloid \u03b2 clearance in a mouse model of Alzheimer\u2019s disease","volume":"741","author":"Sasaki","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.mcn.2026.104091_bb0295","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.3390\/ijms22189987","article-title":"Insulin and insulin resistance in Alzheimer\u2019s disease","volume":"22","author":"S\u0119dzikowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.mcn.2026.104091_bb0300","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/alz.12322","article-title":"Replication study of plasma proteins relating to Alzheimer\u2019s pathology","volume":"17","author":"Shi","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2026.104091_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.955113","article-title":"Exendin-4 alleviates \u03b2-amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer\u2019s disease","volume":"14","author":"Song","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.mcn.2026.104091_bb0310","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaneurol.2025.0353","article-title":"GLP-1RA and SGLT2i medications for type 2 diabetes and Alzheimer disease and related dementias","volume":"82","author":"Tang","year":"2025","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/imammb\/dqaf003","article-title":"A network-level transport model of tau progression in the Alzheimer's brain","volume":"42","author":"Tora","year":"2025","journal-title":"Math. Med. Biol."},{"issue":"10479","key":"10.1016\/j.mcn.2026.104091_bb0320","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0325","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/1386207325666220726163514","article-title":"Dulaglutide alleviates Alzheimer\u2019s disease by regulating microglial polarization and neurogenic activity","volume":"28","author":"Wang","year":"2025","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.mcn.2026.104091_bb0330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.11.048","article-title":"GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer\u2019s disease models through the Akt\/GSK-3\u03b2\/\u03b2-catenin signaling","volume":"131","author":"Wang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2026.104091_bb0335","doi-asserted-by":"crossref","first-page":"109716","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer\u2019s disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.mcn.2026.104091_bb0340","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","article-title":"Association of insulin resistance with cerebral glucose uptake in late middle\u2013aged adults at risk for Alzheimer disease","volume":"72","author":"Willette","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.mcn.2026.104091_bb0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2015.10.005","article-title":"Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level","volume":"70","author":"Yang","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.mcn.2026.104091_bb0350","doi-asserted-by":"crossref","first-page":"661","DOI":"10.17219\/acem\/121007","article-title":"The role of GLP-1\/GIP receptor agonists in Alzheimer\u2019s disease","volume":"29","author":"Yu","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0400","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/13872877251329439","article-title":"Semaglutide improves cognitive function and neuroinflammation in APP\/PS1 transgenic mice by activating AMPK and inhibiting TLR4\/NF-?B pathway","volume":"105","author":"Zhai","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2026.104091_bb0360","doi-asserted-by":"crossref","first-page":"111529","DOI":"10.1016\/j.mce.2021.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer\u2019s disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.mcn.2026.104091_bb0365","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12264-018-00336-7","article-title":"Liraglutide ameliorates hyperhomocysteinemia-induced Alzheimer-like pathology and memory deficits in rats via multi-molecular targeting","volume":"35","author":"Zhang","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.mcn.2026.104091_bb0370","doi-asserted-by":"crossref","first-page":"108688","DOI":"10.1016\/j.cbi.2019.06.001","article-title":"The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells","volume":"310","author":"Zheng","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.mcn.2026.104091_bb0375","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/JAD-140666","article-title":"Association between stroke and Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"43","author":"Zhou","year":"2015","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.mcn.2026.104091_bb0380","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2019.01.103","article-title":"Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3\u03b2","volume":"511","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:16:37Z","timestamp":1781093797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743126000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"alternative-id":["S1044743126000217"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104091","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104091"}}